Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Jul 19, 2022 · 10-K · 80 days after period end · 0001214659-22-008985
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|
| Net Income | -$3.87M | -$1.26M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Apr 30, 2022 · filed Jul 19, 2022 · 80 d after period end
